The high levels of IFN-γ (Figure 5C), low levels of IL-10 (Figure 5C), and high ratio of IFN-γ/IL-10 (Figure 5C) revealed a Th1 shift in the tumor microenvironment in the MBT-treated tumors. The gene discussed is IFNG; the disease is neoplasm.